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Abstract
Background: Abnormal fatty acid composition (FA) in plasma and tissue lipids frequently occurs in homozygous and even in
heterozygous carriers of cystic fibrosis transmembrane conductance regulator (CFTR) mutations. The mechanism(s)
underlying these abnormalities remained, however, poorly understood despite the potentially CFTR contributing role.
Methodology/Principal Findings: The aim of the present study was to investigate the impact of CFTR depletion on FA
uptake, composition and metabolism using the intestinal Caco-2/15 cell line. shRNA-mediated cftr gene silencing induced
qualitative and quantitative modifications in FA composition in differentiated enterocytes as determined by gas-liquid
chromatography. With the cftr gene disruption, there was a 1,5 fold increase in the total FA amount, largely attributable to
monounsaturated and saturated FA compared to controls. The activity of delta-7 desaturase, estimated by the 16:1(n-7)/
16:0, was significantly higher in knockdown cells and consistent with the striking elevation of the n-7 FA family. When
incubated with [
14C]-oleic acid, CFTR-depleted cells were capable of quick incorporation and export to the medium
concomitantly with the high protein expression of L-FABP known to promote intracellular FA trafficking. Accordingly,
lipoprotein vehicles (CM, VLDL, LDL and HDL), isolated from CFTR knockdown cells, exhibited higher levels of radiolabeled
FA. Moreover, in the presence of [
14C]-acetate, knockdown cells exhibited enhanced secretion of newly synthesized
phospholipids, triglycerides, cholesteryl esters and free FA, thereby suggesting a stimulation of the lipogenic pathway.
Conformably, gene expression of SREBP-1c, a key lipogenic transcription factor, was increased while protein expression of
the phosphorylated and inactive form of acetylCoA carboxylase was reduced, confirming lipogenesis induction. Finally,
CFTR-depleted cells exhibited lower gene expression of transcription factors (PPARa, LXRa, LXRb and RXRa).
Conclusions/Significance: Collectively, our results indicate that CFTR depletion may disrupt FA homeostasis in intestinal
cells through alterations in FA uptake and transport combined with stimulation of lipogenesis that occurs by an LXR/RXR-
independent mechanism. These findings exclude a contributing role of CFTR in CF-associated fat malabsorption.
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Introduction
The basic defect in cystic fibrosis (CF) is caused by mutations in
the epithelial chloride channel, known as the cystic fibrosis
transmembrane conductance regulator (CFTR). Nearly 1500
CFTR mutations have been identified insofar, which contribute
to create a wide spectrum of disease severity. The most common
mutation remained the deletion of a phenylalanine residue at
position 508 (DF508), which causes inappropriate folding of
CFTR, followed by its proteolytic degradation in the endoplasmic
reticulum. This mutation is present in nearly 70% CF patients
while 4% of the general population is estimated to be heterozygous
carriers of DF508. Manifestations of the disease include pancreatic
insufficiency, intestinal fat malabsorption and chronic lung
infections that ultimately lead to pulmonary failure and death [1].
It is widely recognized that disturbances in plasma and tissue
fatty acid (FA) profile constitute a persistent feature of CF.
Multiple studies performed on cellular [2,3] and animal models [4]
of CF as well as on CF-affected individuals and obligate
heterozygous [5] have shown alterations in FA composition,
particularly in the n-6 and n-3 polyunsaturated FA (PUFA).
Decreased levels of linoleic acid (LA; 18:2n-6), docosahexaenoic
acid (DHA; 22:6n-3) and normal to increased levels of arachidonic
acid (AA; 20:4n-6) have frequently been reported in CF plasma,
cells and tissues [5–7]. These abnormalities occur irrespective of
the amount of energy and fat ingested or the pancreatic status,
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suggestive of abnormalities in FA metabolism [8,9]. Further
studies are, however, needed in order to explore the specific
mechanism(s).
Intestinal mucosa represents a tissue particularly sensitive to
changes in FA environment [8]. Enterocyte cell membranes are
particularly rich in LA and AA, and alterations in FA composition
affect membrane fluidity and function of membrane proteins,
modify intracellular phases of fat absorption and influence
eicosanoid production and inflammatory processes [10–12].
Importantly, CF patients are instructed to consume a high-energy,
high-fat diet to minimize the deleterious effects of fat malabsorp-
tion on health [13]. Therefore, intestinal cells are consistently
exposed to high luminal concentrations of FA. With the exception
of one study reporting increased AA and reduced DHA levels in
the ileum of CFTR knockout mice [4], very limited data are
available on intestinal FA composition and metabolism in relation
to CF or CFTR function despite evidence of essential FA
deficiency, intestinal inflammation and abnormalities in enterocyte
lipid trafficking in CF [14–18].
Classically, lipid malabsorption and steatorrhea have been
recognized as secondary manifestations of pancreatic insufficiency
and intra-duodenal acidification [19]. However, a recent work
characterizing post-lipolytic events in duodenal explants of CF
patients has found defects in the intracellular phase of lipid
transport [15]. These findings have raised the possibility that other
factors independently of pancreatic function and luminal environ-
ment might contribute to irregular lipid transport in CF small
intestine. Evidence in support of this hypothesis comes from the
clinical observation that pancreatic enzyme supplementation
coupled to anti-acid therapy could not correct malabsorption
and steatorrhea in CF patients [20,21]. Other studies have
reported a possible link between CFTR function and essential FA
utilization [3,22] but have focused on various models of epithelial
cells other than intestinal cells. Recent work in our lab has
addressed the consequences of reduced CFTR expression on the
handling, transport and secretion of lipids by the intestinal Caco-
2/15 cell line and has shown that CFTR disruption exerted a
stimulated action on intestinal lipid synthesis and transport [23].
This inverse relationship between CFTR expression and intestinal
lipid metabolism indicated that the primary gene defect is not
responsible for the persistent fat malabsorption in CF patients
although variation in CFTR protein expression appears to
regulate lipid homeostasis. In line with our previous work and
considering the possible interaction between CFTR function and
FA homeostasis, we carried out studies to examine the impact of
CFTR depletion on FA uptake, composition and metabolism in
the intestinal Caco-2/15 cell line.
Methods
Cell culture
The colon carcinoma cell line, Caco-2/15 (ATCC, Rockville,
MD), was cultured at subconfluent stages in MEM supplemented
with 5% fetal bovine serum, 1% non-essential amino acids and 1%
Penicillin-Streptomycin (all reagents from Gibco, Grand Island,
NY) as described before [24]. For several experiments, 1610
6 cells
were seeded on 24.5-mm polycarbonate Transwell filter inserts
(Costar, Cambridge, MA) with 0.4-mm pores to allow separate
access to the upper and lower compartments of the monolayer.
Cells were cultured for 12 to 15 days, which represented an
appropriate period to study lipid metabolism in state of full
differentiation [25,26]. Cell differentiation was assessed by
determination of villin protein expression and the integrity of
Caco-2/15 monolayers was confirmed by transepithelial resistance
measurement as described previously [27].
In a subset of experiments, differentiated Caco-2/15 cells were
treated for 3 days with 20 mM of the highly selective CFTR
inhibitor, CFTR-inh172 (Sigma, St-Louis, MO). In order to
maintain continuous CFTR inhibition, culture medium, including
CFTR-inh172 was replenished every 24 h. Cells treated with
0.1% DMSO, the vehicle used to dissolve the inhibitor, served as
controls.
Virus production and cell infection
shRNAs targeting CFTR and individually cloned into plko.1-
puromycin vector (Open Biosystems, Huntsville, AL) were used to
generate lentiviral particles in HEK293FT packaging cells. Cells
were transfected in suspension using the standard calcium-
phosphate method with 5 ug of each of the following DNA
plasmids: pLP1, pLP2, pLP/VSVG and either plko.1 empty
vector, plko.1-containing CFTR shRNA insert or pLentiV5–green
fluorescent protein. The medium was changed 24 h post-
transfection for antibiotic-free DMEM supplemented with 10%
fetal bovine serum, 1% sodium pyruvate (Sigma, St-Louis, MO),
1% non-essential amino acids and 1% GlutaMAX
TM (Gibco,
Grand Island, NY). The viral supernatants were collected 3-days
post-transfection, aliquoted and stored at 280uC. Virus titers were
assessed with the Lenti-X qRT-PCR titration kit (Qiagen,Valen-
cia, CA).
After trypsinization, 1610
6 Caco-2/15 cells were infected in
suspension in the presence of 4 ug/mL of Polybrene (hexadi-
methrine bromide, Sigma, St-Louis, MO). Fresh culture medium
was added 1 h post-infection. After a 3-day-incubation with
lentivirus, cells were trypsinized, transferred to 10-cm
2 dishes and
allowed to grow in presence of the selection antibiotics, puromycin
(Sigma, St-Louis, MO). When cells reached 80% confluence, they
were plated at a density of 1610
6cells on 24.5-mm polycarbonate
Transwell filter inserts and allowed to differentiate in the presence
of puromycin. Infection efficiency was assessed by the monitoring
of green fluorescent protein expression in cells infected with
lentivirus carrying the green fluorescent protein. Cells mock-
infected with the empty vector plko.1 served as controls since
preliminary experiments have shown comparable gene and
protein CFTR expression between mock and non-treated cells.
Fatty acid analysis
Following differentiation, Caco-2/15 cells were serum-starved
for 24 h before being homogenized in PBS supplemented with
1 mM of anti-proteases and 0.01% butylated hydroxytoluene
(BHT; Sigma, St-Louis, MO). Samples were subjected to
transesterification and injected into a gas chromatograph using a
90 m60.32 mm WCOT-fused silica capillary column VF-23ms
coated with 0.25 mm film thickness (Varian, Canada) according to
the method described previously [28].
RNA isolation and RT-PCR
Total RNA was extracted from differentiated Caco-2/15 cells
using Trizol (Invitrogen, Carlsbad, CA) and complementary DNA
generated using the Moloney Murine Leukemia Virus reverse
transcriptase (Invitrogen, Carlsbad, CA) according to manufac-
turer’s instructions. PCR reactions for CFTR, transcription factors
[(liver X receptors (LXRs), retinoid X receptors (RXRs),
peroxisome proliferators-activated receptors (PPARs) and sterol
regulatory element binding protein-1c (SREBP-1c)] and GAPDH
(as a house-keeping gene) were set up using intron-spanning
primers and performed on a GeneAmp PCR System 9700
(Applied Biosystems, Foster City, CA) as described previously [29].
CFTR and Intestinal Fatty Acid
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target at 95uC for 30 seconds, 53–62uC for 1 min and 72uC for
1 min. The number of cycles corresponds to the linear portion of
the exponential phase for each gene expression and was assessed in
preliminary studies.
Immunoblotting
Mock-infected and CFTR knockdown cells were homogenized
after 14 days of differentiation and prepared for Western blot as
described before [30]. Briefly, 20 mg of total proteins were
fractionated on a SDS-PAGE gel and blotted onto nitrocellulose
membrane. After a blocking step consisting of a short incubation
(1 h) with 5% of nonfat milk, membranes were probed overnight
with 1:5000 anti-Fatty acid translocase/cluster determinant 36
(FAT/CD36; Santa Cruz, Santa Cruz, CA), 1:1000 anti-L-fatty
acid binding protein (L-FABP; prepared in our lab), 1:1000 anti-
CFTR, acetyl-CoA carboxylase (ACC), AMP-activated protein
kinase (AMPK), phosphorylated ACC or phosphorylated AMPK
(Cell Signaling, Danvers, MA) or 1:40 000 anti-b-actin (Sigma, St-
Louis, MO) followed by a 1-h-incubation with species-specific
horseradish peroxidase-conjugated secondary antibodies (at a
1:10000 dilution) and revealed using the chemiluminescent
reagent Luminol (Roche Diagnostics, Mannheim, Germany).
The films were quantified by computer-assisted scanning densi-
tometry using UN-SCAN-IT software (Silk Scientific, Orem, UT).
Isolation and analysis of intracellular lipid fractions and
lipoproteins
Caco-2/15 cells were differentiated for 10 days on polycarbon-
ate Transwell filter inserts as described above. Lipid synthesis was
determined as described previously [24]. On day 10, fetal bovine
serum was omitted from the cell culture medium and cells were
preincubated with 1 mmol/mL of cold oleic acid. After a 24-h
preincubation, 0.45 mCi/well of [
14C]-oleic acid (specific activity
of 55 mCi/mmol; GE Healthcare, Piscataway, NJ) was added in
the upper compartment of the Transwell for another 24-h period.
Basolateral media were subsequently collected and cells were
rinsed twice in ice-cold PBS and lysed in a buffer consisting of
10 mM Tris, 150 mM NaCl, 0.025% sodium azide, 5 mM
EDTA, 0.1% SDS, 1% Triton X100 and 0.5% sodium
desoxycholate together with 1 mM of each antiprotease: pepstatin
A, PMSF and aprotinin. Cell protein was quantified by the
Bradford method (BioRad, Hercules, CA). Cell homogenates and
basolateral media were lipid-extracted with chloroform/methanol
(2:1, vol:vol) and lipids were separated by thin-layer chromatog-
raphy (TLC) using the solvent mixture: hexane/ethyl ether/acetic
acid (80:20:3, (vol:vol:vol)). The area corresponding to the free
fatty acids (FFA) was excised from the TLC silica plates,
transferred to scintillation vials with 10 mL of scintillation fluid
(Beckman-Coulter, Fullerton, CA) and radioactivity measured.
Quenching was corrected using computerized curves generated
with external standards.
Lipoproteins were isolated from basolateral media by serial
ultracentrifugation using a TL-100 ultracentrifuge (Beckman-
Coulter, Fullerton, CA) according to the method described
previously [31]. Briefly, chylomicrons (CM) were first isolated
after an ultracentrifugation at 25 000 g for 40 min. Very-low-
density lipoprotein (VLDL; 1.006 g/mL) and low-density lipopro-
tein (LDL; 1,063 g/mL) were subsequently separated by centri-
fugation at 100 000 g for 2.5 h. High-density lipoprotein (HDL)
fraction was obtained after adjusting the LDL infranatant to a
density of 1.21 g/mL and centrifuging for 6 h at 100 000 g. Each
lipoprotein fraction was dialyzed against 0.15 M NaCl and
0.001 M EDTA, pH 7.0 at 4uC for 24 h. Lipids from each
lipoprotein were extracted with chloroform/methanol and the
FFA fraction analyzed as described in details above.
Lipid carrier
Blood (20 mL) was collected by venipuncture 2–3 h after the
ingestion of a high fat meal (50 g/1,73 m
2) from two human
healthy volunteers. This procedure was approved by the
Institutional Ethic Committee. After a 10006g centrifugation to
pellet red blood cells, postprandial plasma was supplemented with
1 mM of aprotinin and 0.1% of sodium azide and was mixed with
Figure 1. CFTR gene and protein knockdown following
lentivirus infection of Caco 2/15 cells. After lentivirus infection,
Caco 2/15 cells were differentiated for a period of 14 days before being
assessed for CFTR gene and protein expression by RT-PCR and Western
Blot, respectively. Cells that were not infected with lentivirus served as
controls and represent 100%. Cells infected with the empty vector
(indicated as Mock Cells on the graph) exhibited comparable CFTR
expression relatively to noninfected cells. Results represent mean6 SEM
of n=5 independent cell preparations and are illustrated as % of the
noninfected cells after the data have been calculated as densitometric
ratio of CFTR to GAPDH or b-actin. *p,0,01.
doi:10.1371/journal.pone.0010446.g001
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CM as described previously [24].
De novo lipogenesis
Caco-2/15 cells were serum-starved after 12 days of differen-
tiation on Transwell filter inserts. After 24-h-incubation in serum-
free medium, cells were cultured in the presence of 5 mCi of
sodium-[
14C]-acetate (specific activity of 50–62 mCi/mmol; GE
Healthcare, Piscataway, NJ) for the same length of time. Cells and
media were collected, supplemented with a mixture of anti-
proteases and lipids were extracted overnight in chloroform-
methanol (2:1, vol:vol). Lipids recovered were separated on TLC
plates, and bands corresponding to phospholipids (PL), FFA,
triglycerides (TG) and cholesteryl ester (CE) were scraped off the
plates, mixed with scintillation fluid and counted for the amount of
radioactivity incorporated as described previously [32].
Statistical analysis
Data are presented as means 6 SEM. To account for the inter-
variability between experiments, some data are given as
percentage of mock-infected cells. Student’t test was used for
statistical analysis of differences between means and cut-off point
for significance was set at P,0.05.
Results
Influence of CFTR knockdown on FA concentration and
composition
We used the shRNAi experimental approach to generate a
model of Caco-2/15 cells deficient in CFTR. Infection of Caco-2/
15 cells with lentivirus carrying CFTR-shRNAi caused a reduction
in CFTR gene (61%) and protein (57%) expression when
compared to non-infected cells (Figure 1). Mock-infected cells
expressed a level of CFTR gene and protein, which was similar to
non-infected cells and were, therefore, used as controls in
subsequent experiments. Cell viability, integrity and differentiation
state were not altered by genetic manipulation (data not shown).
FA composition of cell homogenates were assessed by gas
chromatography and comparisons were set up between control
mock and knockdown cells. Total amount of FA increased by 1.5-
fold upon CFTR gene disruption (Figure 2). This raised level was
imputed to increased levels of specific FA species, including
monounsaturated (50%), and saturated (49%) FA relatively to
mock-infected cells. In particular, the total n-7 FA levels
(236.567.0 mM/mg protein vs 416.8660.4 mM/mg protein)
experienced the highest increase (76% over mock values) whereas
total n-9 FA levels (252.7625.2 mM/mg protein vs
319.4619.4 mM/mg protein) were only moderately raised (26%
over control values). The proportions of individual FA are
summarized in Table 1. CFTR knockdown resulted in a marked
increase in the amounts of myristic (14:0) and palmitic (16:0) FA,
while stearic acid (18:0) and longer saturated FAs displayed
reduced values (P,0.05). As a consequence of CFTR genetic
manipulation, n-7 FAs appeared elevated whereas n-3 and n-6
FAs remained unchanged. Proportions of n-9 FA were reduced to
various degrees in knockdown cells with oleic acid (18:1n-9)
exhibiting the highest, albeit non-significant, decrease compared to
mock cell values.
The ratio of 16:1 (n-7)/18:2 (n-6), an established index of
essential FA status [33], was increased by 2-fold in CFTR-depleted
cells (Table 2). Similar trend was also observed for the 20:3 (n-9)/
20:4 (n-6) and the DHA/AA ratio. Finally, the activity of delta-7
and delta-9 desaturases, estimated by the 16:1(n-7)/16:0 and the
18:1(n-9)/18:0 ratios, was significantly higher in CFTR knock-
down cells than mock-infected cells whereas the delta-6 desaturase
index, 20:3 (n-6)/18:2 (n-6), was reduced.
To further confirm the influence of CFTR on FA concentration
and composition, we examined the effect of the CFTR inhibitor,
CFTR-inh172, that selectively blocks CFTR chloride conduc-
tance. In preliminary experiments, Trypan blue exclusion test and
MTT assay were performed to assess cytotoxicity of this
compound. Over 98% viability was recorded in cells treated with
this chemical agent, and MTT values were not different between
DMSO and CFTR-inh 172 treated cultures (data not shown).
Pharmacological inhibition of CFTR led to modest but statically
Figure 2. Influence of CFTR knockdown on total fatty acids (FA) content and FA classes in Caco-2/15 cells. At 15 days of differentiation,
cells were collected, subjected to direct transesterification and injected into a gas chromatograph. Results represent the means 6 SEM of 4
independent experiments and are illustrated as mg/mg of cellular protein. *p,0.05 vs mock cells. SFA: saturated fatty acids; MUFA: monounsaturated
fatty acids; PUFA; polyunsaturated fatty acids.
doi:10.1371/journal.pone.0010446.g002
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monounsaturated FA, which resulted in a higher total FA content
(Figure 3). Similarly to CFTR knockdown cells, CFTR-inh172-
treated cells displayed a higher n-7 FA content and no significant
alterations in the concentrations of n-3 and n-6 FAs. Besides, total
n-9 FA exhibited a tendency toward increased values.
Influence of CFTR knockdown on FA uptake and output
To verify whether changes in FA concentration might be
accounted for by alterations in FA uptake and output by the
intestinal cell, we incubated cells with a common dietary FA,
[
14C]-oleic acid, and determined the amount of radioactivity
present in various cellular and secreted lipid fractions. CFTR
knockdown cells displayed a 4-fold increase in the amount of FFA
exported to the basolateral medium whereas no changes were
recorded in the cellular amount of FFA (Figure 4). Subsequently,
we measured the amount of FA transported by the lipoprotein
classes: CM, VLDL, LDL and HDL isolated from CFTR
knockdown cells. They displayed higher levels of FFA compared
to control mock-infected cells: 186%, 153%, 143%, and 719%,
respectively (Figure 5).
Protein expression of transporters involved in FA uptake
by intestinal cells
To elucidate the mechanisms underlying the significant raise of
FA upon reduction in CFTR expression, we assessed the
expression of two proteins involved in FA intestinal uptake and
transport. First, the protein expression of FAT/CD36, a
transporter involved in FA uptake, displayed a 1,5-fold increase
in CFTR-depleted cells (Figure 6A) although this difference did
not reach the significance threshold (p,0.09). Conversely, the
protein expression of L-FABP that participates mainly in
intracellular FA trafficking was increased by almost 2-fold in
CFTR knockdown cells (Figure 6B).
De novo lipogenesis
We next examine the possibility that de novo lipogenesis could be
stimulated in a state of CFTR depletion. To verify this hypothesis,
we first incubated cells with [
14C]-acetate, a major substrate for de
novo lipogenesis and we assessed the amount of radioactivity
incorporated into various lipid fractions in cell homogenates and
in media. The amount of newly synthesized cellular lipids
remained similar between control and genetically modified cells
(Figure 7A). The major difference was, however, noted in the total
amount of secreted lipids, which exhibited a 1.8-fold increase in
CFTR knockdown cells (Figure 7B). This increase was largely
attributed to the rise in the levels of PL, TG and CE. Consistent
with the findings obtained with [
14C]-oleic acid experiments,
CFTR knockdown cells displayed higher levels of secreted FA than
mock-control cells following [
14C]-acetate incubation whereas
cellular level of FFA exhibited a downward tendency at the
expense of increased secretion documented by the augmented
output of PL, TG and CE (Figure 8). These findings were further
substantiated by the calculation of medium-to-cell ratios for each
lipid fractions (Figure 7C and 8C). Significant higher ratios were
found for all fractions following CFTR depletion, which indicated
a marked lipid secretion to the medium.
The mechanisms for the modifications of de novo lipogenesis
were further investigated by examining key regulatory protein
players involved in this metabolic pathway. We focused on
AMPK that currently comes into a spotlight as an important
regulator for lipid metabolism by modulating phosphorylation
and activity of the key ACC enzyme. To this end, we performed
Table 1. Fatty acid composition in Caco-2/15 cells.
Fatty acids Mock (%) CFTR Knockdown (%) p-Value
14:0 1.4960.25 2.6860.03 ,0.05
15:0 0.7260.01 1.6360.16 ,0.05
16:0 14.9261.01 18.1760.19 ,0.05
17:0 0.7060.00 0.7760.10
18:0 8.4160.37 4.6460.04 ,0.05
20:0 0.5360.03 0.2760.01 ,0.05
22:0 0.5660.04 0.2760.00 ,0.05
24:0 1.3660.06 0.6260.03 ,0.05
18-3 (n-3) 0.0260.00 0.0260.0
20:3 (n-3) 0.0160.00 0.0160.00
20:5 (n-3) 0.4260.05 0.2160.05 ,0.05
22:5 (n-3) 0.3360.01 0.4060.03
22:6 (n-3) 0.8160.03 0.7860.13
18:2 (n-6) 0.6360.06 0.4660.06
20:2 (n-6) 0.0660.01 0.0460.00
20:3 (n-6) 0.3660.04 0.2160.04
20:4 (n-6) 2.0660.21 1.4660.19
22:4 (n-6) 0.1560.01 0.5660.40
16:1 (n-7) 8.4060.06 13.2060.07 ,0.05
18:1 (n-7) 22.2960.66 23.2161.50
18:1 (n-9) 26.7561.58 23.7461.04
20:1 (n-9) 1.6860.03 1.3360.01 ,0.05
22:1 (n-9) 2.8960.12 1.9860.14 ,0.05
24:1 (n-9) 1.2760.05 0.9760.00 ,0.05
Total n-3 1.6060.09 1.4260.21
Total n-6 3.3760.32 2.7860.09
Total n-7 30.7660.59 36.4361.57 ,0.05
Total n-9 32.7561.68 28.1661.18
After 15 days of differentiation, cells were serum-starved and collected for fatty
acid analysis. Cells were then subjected to transesterifiation and injected into a
gas chromatograph. Results are expressed as % of total fatty acid content. Data
represent the means6SEM of four independent wells.
doi:10.1371/journal.pone.0010446.t001
Table 2. Ratios and desaturation indexes in Caco-2/15 cells.
Fatty acid Mock CFTR Knockdown p-Value
16:l (n-7)/18:2(n-6) 13.4861.26 29.0463.78 ,0.05
20:3(n-9)/20:4(n-6) 0.07360.004 0.09360.005 ,0.05
EFA/non-EFA 0.00760.001 0.00560.001
DHA/AA 0.39860.026 0.53460.016 ,0.05
Desaturation indexes
D6 20:3(n-6)/18:2 n-6 0.56460.005 0.44260.026 ,0.05
D9 18:1 n-9/18:0 3.19560.329 5.11160.177 ,0.05
D7 16:1 n-7/16:0 0.56660.042 0.72660.004 ,0.05
Student’s t test (two-tailed) was used to compare differences between means
(X6SEM).
EFA: essential fatty acids, AA: arachidonic acid, DHA: docosahexaenoic acid.
doi:10.1371/journal.pone.0010446.t002
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PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e10446Figure 3. Influence of pharmacological inhibition of CFTR on fatty acid concentrations in Caco-2/15 cells. Treatment with 20 mM CFTR
inh-172 at 12 days of differentiation was initiated and maintained for 3 days. Cells treated with DMSO (vehicle) served as controls. Cells were collected
and subjected to direct trans-esterification and injected into a gas chromatograph. Result represent the means 6 SEM of n=3 to 4 separate wells
originating from 3 independent experiments and are illustrated as mg/mg of cellular protein. *p,0.05 vs DMSO-treated cells. SFA: saturated fatty
acids; MUFA: monounsaturated fatty acids; PUFA; polyunsaturated fatty acids.
doi:10.1371/journal.pone.0010446.g003
Figure 4. Total, cellular and medium free fatty acid (FFA) content of Caco-2/15 cells. Mock-infected and knockdown cells were
differentiated for 12 days and incubated with [
14C]-oleic acid for 24 h. Lipids of cell homogenates and medium were extracted with chloroform-
methanol, isolated by TLC and the radioactivity incorporated into FFA fraction determined. Results were analyzed as dpm/mg of total protein but
were reported as a proportion of mock-infected values representing 100%. Data represented means 6 SEM of n=3 independent experiments.
*p,0.05 vs mock cells.
doi:10.1371/journal.pone.0010446.g004
CFTR and Intestinal Fatty Acid
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phosphorylation (p-AMPK and p-ACC) in control and CFTR
knockdown cells. CFTR-depleted cells displayed lower AMPK
levels than controls without significant changes in the p-AMPK
form, thereby resulting in a higher, although non-significant, p-
AMPK/AMPK ratio (Figure 9A). On the other hand, we
observed a significant decrease in the amount of p-ACC upon
CFTR genetic manipulation, which was coupled to an increased
trend of total ACC, leading to a marked decrease in the
calculated ratio of p-ACC/ACC (Figure 9B). These data are
suggestive that CFTR knockdown leads to a stimulation of the
active form of ACC at the cellular level, thereby providing a
molecular explanation for the enhancement in de novo lipogenesis.
Since the induction of ACC gene transcription is under the
regulatory action of SREBP-1c that binds the sterol response
elements located in the ACC promoter, we determined its gene
expression. In line with the enhanced lipogenesis and the
decreased phosphorylation state of ACC, CFTR knockdown
resulted in a significant increase in SREBP-1c gene expression
(Figure 10).
Figure 5. Free fatty acid (FFA) content in lipoproteins secreted by Caco-2/15 cells. Cells infected with empty vector plko.1 or infected with
lentivirus carrying CFTR-shRNAi were differentiated for 12 days and incubated with [
14C]-oleic acid for 24 h. Thereafter, lipoproteins were isolated by
ultracentrifugation according to their specific densities. Lipoprotein lipids were further extracted using a mixture of chloroform/methanol, spreaded
onto TLC plates and the band corresponding to the FFA fraction was scraped off the plates. Radioactivity incorporated was further determined. Data
were analyzed as dpm/mg of total protein but were reported as percent difference relative to plko.1-infected values representing 100%. Data
represented means 6 SEM of n=3 independent experiments. *p,0.05 vs mock cells. CM: chylomicron; HDL: high density lipoprotein; LDL: low
density lipoprotein; VLDL: very-low density lipoprotein.
doi:10.1371/journal.pone.0010446.g005
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In an attempt to elucidate potential mechanisms linking CFTR
to FA metabolism, we determined the status of several transcrip-
tion factors that govern the expression of a variety of genes
associated with lipid and cholesterol metabolism. Data regarding
the gene expression of members of the PPAR family are presented
in Figure 11. CFTR disruption did not influence the expression of
PPAR-b and PPAR-c whereas a 2-fold reduction was observed in
PPAR-a mRNA levels. Consistent with these data, a significant
transcript decline characterized RXR-a (acting as a partner of
PPAR-a), while the gene expression of RXR-b remained
unaltered (Figure 12A). The most striking observation, in response
to CFTR knockdown, was the downregulation of LXR-a and
LXR-b mRNA (Figure 12B).
Discussion
The mechanisms involved in the regulation of FA metabolism
by CFTR are largely unknown despite recurrent evidences of
abnormal FA composition and lipid profile in CF patients and
heterozygous carriers of CFTR mutations [5,7]. If numerous
studies have examined the FA status in various cell types derived
from CF patients, very few investigations have focused on the
functional role of CFTR [3,6]. Recent observations made by our
group have suggested the implication of the chloride channel
CFTR in the modulation of intestinal lipid handling and transport
[23]. The present work considerably confirms and extends this
concept by highlighting the impact of partial CFTR deletion on
the composition, uptake and biogenesis of FAs in intestinal Caco-
2/15 cells. In particular, we could document that disruption of
CFTR expression led to a higher cellular FA content characterized
by an elevated proportion of saturated and n-7 FA. We showed
that the mechanism for the elevation of FA concentrations was
mainly attributable to increased de novo lipogenesis. We have
provided direct evidence for a role of ACC-mediated FA synthesis
in line with SREBP-1c upregulation. Our results also indicate the
relationship of CFTR depletion with enhanced FA uptake and
transport via different lipoprotein classes. Finally, specific
transcription factors involved in the regulation of lipid metabolism
are strongly suppressed in the presence of reduced CFTR
expression.
The present findings are in line with many other studies
showing that plasma fractions of CF patients display elevated
concentrations of 14:0, 16:0 and 16:1n-7 FA whereas 18:0 FA
levels remain unchanged or slightly decreased [7,34]. However,
plasma FA largely represented a transport pool rather than a
functional pool, which therefore underscores the importance of
studying FA composition of CF-affected tissues and cells. Various
studies performed on human biopsies [5], postmortem tissues [35],
animal [4,36] and cellular models [2,3,6] have reported FA
abnormalities especially in the PUFAs. Mechanisms underlying
these perturbations are still unclear but may be linked to dietary
fat malabsorption and/or altered FA metabolism such as increased
b-oxidation or lipid peroxidation as a consequence of oxidative
stress, altered desaturase activity, enhanced production of
eicosanoids and defective CFTR. However, data on intestinal
FA distribution remained scarce and have been mostly reported in
CF mice model with diverging conclusions attributable to
confounding variables such as age, types of mice models and
diets [4,37,38]. Using the intestinal Caco-2/15 cell model, we
could show that, reduced CFTR expression distinctively affects the
different classes of FA. While it exerts no particular influence on
Figure 6. Effect of CFTR knockdown on protein expression of CD36 (A) and L-FABP (B). After 15 days of differentiation, Caco-2/15 cells
were lysed and protein expression determined by Western Blot. b-actin served as loading control and was used for normalization. Data represented
means 6 SEM of three to four independent experiments *p,0.05 vs mock cells.
doi:10.1371/journal.pone.0010446.g006
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saturated FA family displays two opposed subclasses: saturated FA
with 17 carbons and less exhibit higher concentrations in CFTR
knockdown compared to control cells whereas longer saturated FA
display reduced levels. Although, this dichotomy had recurrently
been demonstrated in the plasma of CF patients [7,33], the
biological relevance and the mechanisms underlying these changes
have been rarely explored and discussed despite the fact that they
may be highly suggestive of abnormalities in tissue FA metabolism.
Calculation of the desaturase ratios corroborates the assumption
that FA metabolism is indeed altered in CFTR-depleted cells.
Product-to-substrate ratio is good surrogate marker for desaturase
activity in blood and tissue [33,39]. Delta-7 and -9 desaturases
catalyze the conversion of 16:0 into 16:1n-7 and 18:0 into 18:1n-9,
respectively, the latter being a major constituent of TG. It has
been reported that induction of delta-9 desaturase activity is
observed in situations characterized by an increased demand for
unsaturated FA [40]. We previously showed that CFTR-depleted
cells exhibited enhanced TG esterification and lipoprotein
assembly, both requiring unsaturated FA species [23]. Strong
induction of delta-7 and -9 desaturase activities in knockdown cells
may, therefore, be secondary to enhanced cellular requirement for
unsaturated FA species. Although, there was no statistical
differences between mock and CFTR knockdown cells in term
of n-6 FA concentrations, CFTR-depleted cells displayed a lower
delta-6 desaturase index suggesting impaired conversion of 18:2,
n-6 to more desaturated products. In contrast, treatment with the
CFTR inhibitor, CFTR inh-172, led to an increase in all
desaturase indexes (data not shown), which is concordant with a
previous study performed in CF patients [33]. These observations
suggest that the reduction of cellular content of CFTR protein
exerts an impact on n-6 FA desaturation quite distinct from that
Figure 7. Influence of CFTR knockdown on de novo lipogenesis in Caco-2/15 cells. After 12 days of differentiation, cells were incubated
with [
14C]-acetate for 24 h. Cells (A) and media (B) were further collected and lipid-extracted in chloroform/methanol. The extracts were separated on
silica plates and bands corresponding to TG, PL and CE were excised. Radioactivity incorporated into each fraction was counted. The discrepancy
between synthesis of newly formed lipids and their secretion became evident when expressed as a medium/cell ratio (C). Data represented means 6
SEM of n=12 wells from two independent experiments. *p,0.05 vs mock cells. TG: triglycerides; PL: phospholipids; CE: cholesteryl ester.
doi:10.1371/journal.pone.0010446.g007
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are necessary to delineate the mechanisms and increase our
understanding on the role of CFTR protein content and activity in
lipid transport and metabolism.
Deeper explorations of FA uptake and transport, using the
monounsaturated [
14C]-oleic acid, demonstrates that CFTR-
depleted intestinal cells exhibit enhanced uptake of oleic acid,
which translates in its increased secretion in the unesterified form.
These findings are further substantiated by the enhanced L-FABP
expression and a trend toward increased expression of the FA
membrane transporter, FAT/CD36. L-FABP involvement in FA
uptake has been reported in numerous investigations. Mice treated
with clofibrate, a known activator of L-FABP, displayed enhanced
liver FA uptake, intracellular diffusion and efflux [41]. Moreover,
L-FABP disruption was associated with the stimulation of FA
uptake both in fibroblasts and in l-fabp null mice [42,43].
Under normal physiological conditions, the metabolic fate of FFA
is to participate in sequential esterification reactions leading to the
formation of TG, PL and CE that are subsequently packaged into
lipoproteins and exported from the enterocyte, thereby explaining
why lipoproteins carry very little amount of non-esterified FAs. Non-
esterified FAs escaping the esterification pathway predominantly
enter blood circulation bound to albumin or served to fuel
mitochondrial b-oxidation. The high medium-to-cell ratios observed
in CFTR knockdown cells demonstrated that these cells are
particularly efficient at exporting lipids thereby strengthening the
fact that lipid accretion acts as a trigger for stimulation of lipid
transport. However, apart from increasing its buffer capacity through
upregulation of L-FABP expression, Caco-2/15 cells appear to
challenge the FA overload by efficiently channeling FAs toward the
lipoprotein secretory pathways, i.e. the endoplasmic reticulum. It has
been shown in several cellular models that the exposition to high
concentrations of saturated and unsaturated FA promotes TG
synthesis and prevents lipotoxicity by sequestering FFA that are
otherwise cytotoxic [44]. In the present case, increased lipoprotein
content of FFA represents a novel and non-classical pathway that
may fulfill the same role of protecting the cell against FA overload.
Since CFTR knockdown cells exported more lipids than mock cells
but still exhibited a higher cellular FA content, we speculate that
CFTR depletion leads to an inappropriate homeostatic response to
FA accumulation where the increasing amount of cellular FA is
preferably incorporated and secreted into lipoproteins. Reduction in
CFTR expression appears to cause a shift in the balance between
energy-yielding and energy-consuming reactions in favor of the latter.
To support this claim, we found that, when CFTR-depleted cells
wereincubatedwith[
14C]-acetate,themajor lipogenic substrate, they
displayedanenhancedoutputofnewlysynthesizedFFA,TG,PLand
CE compared to mock-infected cells. These findings were further
confirmed by the assessment of p-ACC protein and SREBP-1c
mRNA levels. ACC is the key enzyme catalyzing the conversion of
acetyl CoA into malonyl CoA which is subsequently converted to
palmitate under the control of the FA synthase whereas SREBP-1c is
a transcription factor involved in the control of the expression of
lipogenic genes. In CFTR-depleted cells, the mass of p-ACC, the
inactive form of the protein, was significantly reduced resulting in a
decreased p-ACC to total ACC ratio indicative of increased activity.
Consistent with these data, SREBP-1c gene expression was also
increased.Likewise,arecentstudyhasreportedanincreasedSREBP-
1c expression and activity in CF dendritic cells [45]. Collectively,
these data support a role for CFTR in the control of intestinal
lipogenesis. However, additional studies are clearly needed to clarify
the impact of CFTR depletion on the FA oxidation status especially
in view of a recent report suggesting an impairment of b-oxidation in
CF patients [46].
Why would intestinal cells, not recognized for lipid storage, exhibit
enhanced lipogenesis in a state of CFTR depletion? Moreover, why
would CFTR knockdown cells demonstrate increased lipogenesis and
FA uptake, two processes leading to cellular FA accretion and
stimulation of FA incorporation and secretion into lipoproteins?
Although counterintuitive, this situation is not unique to our model
and resembles in many aspects to what is observed in enterocytes
isolated from fructose-fed hamster, an animal model of insulin
resistance. In this model, overproduction of intestinal apolipoprotein
B48-containing lipoprotein was closely associated with stimulation of
intestinal de novo lipogenesis [47].
Genetic and pharmacological manipulation of CFTR led to
comparable changes in cellular FA profile, which strongly
indicates that CFTR plays a role in the regulation of intestinal
Figure 8. Impact of CFTR knockdown on newly synthesized (A),
secreted (B) free fatty acid (FFA) and on the medium to cell
ratio (C). After a 24 h-incubation with [
14C]-acetate, cells and media
were collected, lipids were extracted in chloroform/methanol and
separated by TLC. The FFA band was scraped off the plate and counted
for the amount of radioactivity incorporated. Data represented means
6 SEM of n=12 wells from two independent experiments. *p,0.05 vs
mock cells.
doi:10.1371/journal.pone.0010446.g008
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inhibitor were, however, less pronounced than those induced by
CFTR deletion, thereby suggesting that blocking chloride
conductance is one of the prerequisites for perturbations of
intestinal FA metabolism. Even if blocking chloride conductance
was previously shown to disturb the FA profile of airway
epithelial cells [22], reduction in the cellular content of CFTR
appears to exert additional influences. In fact, lack of CFTR at
the plasma and subcellular membranes may affect biophysical
properties, thereby culminating in alterations of various func-
tions, including lipid synthesis and transport. Furthermore,
CFTR depletion may hamper the potential interactions with
other proteins, including transporters, receptors and signalling
proteins.
Using several experimental approaches, our data strengthen the
notion that CFTR is involved in the regulation of intestinal FA
metabolism through modulation of the lipogenic pathway.
Previous evidence has suggested that CFTR interacted with
AMPK, which is involved in the regulation of cellular energy
homeostasis [48,49]. AMPK activity is stimulated when the
intracellular energy status is low (i.e increased in AMP/ATP
ratio). The action of AMPK is aimed at increasing the production
of ATP by enhancing FA oxidation and inhibiting FA biosynthesis
through p-ACC. ACC deactivation leads to carnitine palmitoyl-
transferase inhibition, thereby facilitating mitochondrial FA
uptake and catabolism. Since AMPK colocalizes with CFTR
and given that both entities appear to exert an influence on each
other [48,49], it is tempting to postulate that CFTR depletion
would enhance lipogenesis through modulation of AMPK activity.
This hypothesis turns out to be false. Levels of p-AMPK were not
significantly altered in the CFTR depletion condition whereas the
mass of total AMPK was significantly reduced resulting in an
upward, albeit moderate, shift of the p-AMPK to total AMPK
ratio, an index of AMPK activity. These results were unexpected
Figure 9. Impact of CFTR knockdown on the protein expression of (A) AMP-activated protein kinase (AMPK) and (B) acetylCoA
carboxylase (ACC) in Caco-2/15 cells. Phosphorylated AMPK (p-AMPK) and ACC (p-ACC) and total AMPK and ACC were analyzed by Western Blot
and the ratios of phosphorylated form to total protein level were calculated. Results are expressed as means 6 SEM of n=3 independent
experiments. *p,0.05 vs mock cells.
doi:10.1371/journal.pone.0010446.g009
CFTR and Intestinal Fatty Acid
PLoS ONE | www.plosone.org 11 May 2010 | Volume 5 | Issue 5 | e10446giving that numerous studies have reported that p-ACC remained
under the control of AMPK. Dissociation between activation of
AMPK and p-ACC has been documented in ischemic kidneys
[50] as well as in muscle following prolonged exercise [51]. More
importantly, defective FA oxidation has been suggested in CF
[46], which is in agreement with the idea of an uncoupling
between AMPK activity and the control of FA anabolic and
catabolic pathways under a state of CFTR depletion.
Our data showed a reduction in the expression of several
transcription factors involved in the control of cholesterol and FA
metabolism in CFTR-depleted cells. PPARa expression, whose
activation is normally induced by PUFA, was markedly suppressed in
CFTR knockdown cells despite unchanged cellular levels of n-3 and
n-6 FAs. The LXR family of transcription factors regulates a wide
array of genes, including SREBP-1c and ACC. Surprisingly, CFTR
depletion leads to the suppression of the gene expression of both LXR
members, therefore suggesting that regulation of SREBP-1c and
ACC occurs in a LXR-independent manner. This situation is very
similar to the effects of a high-glucose diet, which induces, even in the
absence of LXR, liver expression of several lipogenic genes, including
ACC [52]. The mechanisms underlying the suppression of PPARa,
LXRs and RXRa and their relation CFTR depletion are still
unknown and need to be further investigated.
High concentrations of TG and fasting hypertriglyceridemia are
frequently encountered in CF patients [53]. The reasons
underlying these conditions are not well understood but have
been related to chronic low-grade inflammation and imbalance in
dietary macronutrients intake in favor of carbohydrates [53].
Increased intestinal synthesis of CM and of their major protein
component, apolipoprotein B48, have been identified as important
contributors to the dyslipidemia associated with insulin-resistant
and diabetic states [47,54,55]. As demonstrated previously, CFTR
depletion in Caco-2/15 cells has led to the enhancement of
apolipoprotein B biosynthesis and the assembly of CM. Further-
more, the present findings have revealed that CFTR reduced
expression is associated with increased de novo lipogenesis.
Therefore, we can speculate that the higher-than-normal TG
levels documented in CF patients might be the result of impaired
intestinal lipid metabolism consequent to CFTR depletion.
CF patients are instructed to consume a high calorie, high fat
diet to lessen the detrimental effects of lipid malabsorption that
persists despite tailored pancreatic enzyme supplementation.
Etiology of malnutrition in CF patients includes factors such as
maldigestion, malabsorption, abnormal mucous secretions, poor
Figure 10. Expression of sterol regulatory element binding
protein-1c (SREBP-1c) in response to CFTR knockdown in Caco-
2/15 cells. PCR analysis was performed on cells differentiated for a
period of 15 days. Y-axis represents SREBP-1c expression normalized to
GAPDH expression. Results are expressed as means 6 SEM of n=5
independent experiments. *p,0.05 vs mock cells.
doi:10.1371/journal.pone.0010446.g010
Figure 11. Effect of CFTR knockdown on peroxisome proliferators-activated receptors PPAR(a,b, c) gene expression. Transcript levels
were determined by RT-PCR using RNA extracted from Caco-2/15 cells differentiated for a period of 15 days. Results are expressed as means 6 SEM of
n=5 independent experiments. *p,0.05 vs mock cells.
doi:10.1371/journal.pone.0010446.g011
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secondary to chronic infections [56]. Our findings have, at least,
contributed to exclude CFTR as a causative factor for defective
mucosal uptake and intracellular transport of long-chain FA as
well as impaired intra-enterocyte handling of lipids. Of interest,
our previous studies reported the significant contribution of the
permanent essential FA deficiency to CF malabsorption by
interfering with intra-enterocyte lipid transport [15,57].
We have examined how genetic manipulation of CFTR level
affects Caco-2/15 cell integrity (data not shown). No alterations
were noted in cell viability between control Caco-2/15 cells, mock
cells and Caco-2/15 cells deficient in CFTR. Similarly, estimation
of the expression of the two characteristic brush border membrane
protein markers, villin and sucrase, did not reveal significant
changes, which suggests that genetically modified Caco-2/15 cells
are viable and fully differentiated. Moreover, we assessed
transepithelial electrical resistance, a reliable indicator of the
tightness of the junctions between epithelial cells, which represents
an accurate determination of paracellular permeability [58,59].
Once again, no differences were observed between mock and
knockdown cells, which indicate that CFTR lessening has not
influenced paracellular permeability of oleic acid.
In conclusion, our data bring novel and exciting insights on the
effects of CFTR depletion, at a level seen in heterozygous subjects
and even individuals carrying other CFTR mutations, on intestinal
FA homeostasis. As depicted in Figure 13, CFTR-depleted cells
exhibited significant alterations in FA metabolism as exemplified
by the accumulation of cellular FA, especially saturated and
Figure 12. Effect of CFTR knockdown on gene expression of the nuclear receptors (A) retinoid X receptor (RXR) and (B) liver X
receptor (LXR). Transcript levels were assessed by RT-PCR using RNA extracted from Caco-2/15 cells differentiated for a period of 15 days. Results
are expressed as means 6 SEM of n=5 independent experiments. *p,0.05 vs mock cells.
doi:10.1371/journal.pone.0010446.g012
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transport and stimulation of the lipogenic pathway through
LXR/RXR-independent mechanisms. Modifications in the FA
profile were reproduced to a lesser extent when CFTR was
pharmacologically blocked with the selective inhibitor, CFTR-inh
172 suggesting a direct involvement of CFTR per se. Changes in
intestinal FA metabolism related to defective CFTR may have
deleterious health consequences for CF patients and may explain
certain aberrations in plasma saturated and n-7 FA and
pathophysiological manifestations such as hypertriglyceridemia.
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